GlassScriptPhysician profile
Kiran K Chekka
NPI 1356543235
$692.26
in general payments reported to CMS, 2019-2025
14 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $147 · 2021: $14.31 · 2022: $88.57 · 2023: $65.51 · 2024: $52.48 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $131.11 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $97.10 | 2025 | Austedo Xr, Ajovy |
| Boston Scientific Corporation | $74.95 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $65.51 | 2023 | Zilretta, Iovera, Exparel |
| Nevro Corp. | $54.55 | 2020 | |
| Galderma Laboratories, L.P. | $52.95 | 2019-2021 | |
| Medtronic, INC. | $52.48 | 2024 | Intellis Adaptivestim |
| Bioventus LLC | $37.95 | 2025 | Xcell |
| Stimwave Technologies Incorporated | $36.34 | 2022 | |
| Terumo Bct, INC. | $32.54 | 2022 | |
| Nalu Medical, INC. | $19.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.37 | 2019 | |
| Medtronic USA, INC. | $17.72 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiran Chekka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.